Previous studies have demonstrated that ANGPTL4 can be expressed in coronary heart disease (CHD) (Katanasaka et al., 2022), hypertension (Abu‐Farha et al., 2018), and ischemic stroke (Zheng et al., 2021). Here, ANGPTL4 is linked to coronary artery disorder.